Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study-Reference-Cited by-同舟云学术

Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study

Published:2024-05-13 Issue: Volume: Page:1-9
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Almangour Thamer A.¹^ORCID,Alali Hussain A.²,Alkherb Zakiyah²,Alowais Shuroug A.³⁴⁵,Bin Saleh Khalid³⁴⁵,Almuhisen Sara⁶,Almohaizeie Abdullah⁷⁸,Alsahli Renad¹,Alruwaite Shatha¹,Alnashmi Fai³⁴⁵,Fetyani Lolwa³⁴⁵,Abouobaid Noran Ibrahim⁷,Alghofaily Alnajla⁷,Binkhamis Khalifa M.⁹¹⁰,Alsowaida Yazed Saleh¹¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2. Clinical Pharmacy Services, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

3. Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

4. King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

5. Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia

6. Pharmacy services administration, King Fahad Medical City, Riyadh, Saudi Arabia

7. Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

8. College of Pharmacy, Alfaisal University, Riyadh, Saudi Arabia

9. Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

10. King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia

11. Department of Clinical Pharmacy, College of Pharmacy, University of Ha’il, Hail, Saudi Arabia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2353704

Reference29 articles.

1. Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

2. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review

3. Stenotrophomonas maltophilia: an emerging opportunist human pathogen

4. Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and Clinical Outcomes: Understanding of the Recent Three Years’ Trends

5. Antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia at a teaching hospital in Riyadh, Saudi Arabia;Naeem T;J Ayub Med Coll Abbottabad,2012